DrugPatentWatch Database Preview
Rauwolfia serpentina root - Generic Drug Details
What are the generic sources for rauwolfia serpentina root and what is the scope of freedom to operate?
Rauwolfia serpentina root
is the generic ingredient in eight branded drugs marketed by Bowman Pharms, Phys Prods Va, Panray, Apothecon, Ferndale Labs, Pal Pak, Bundy, Halsey, Impax Labs, Ivax Sub Teva Pharms, Purepac Pharm, Pvt Form, Solvay, Tablicaps, Valeant Pharm Intl, Watson Labs, and Forest Pharms, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for rauwolfia serpentina root.
Summary for rauwolfia serpentina root
| US Patents: | 0 |
| Tradenames: | 8 |
| Applicants: | 17 |
| NDAs: | 19 |
| Drug Master File Entries: | 8 |
| Bulk Api Vendors: | 39 |
| Clinical Trials: | 1 |
| Patent Applications: | 427 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | rauwolfia serpentina root at DailyMed |
Recent Clinical Trials for rauwolfia serpentina root
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
Synonyms for rauwolfia serpentina root
| (19alpha)-16,17-Didehydro-19-methyl-oxayohimban-16-carboxylic acid methyl ester |
| (4S,4aR,13bS,14aS)-methyl 4-methyl- |
| (4S,4aR,13bS,14aS)-methyl 4-methyl-4a,5,7,8,13,13b,14,14a-octahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizine-1-carboxylate |
| (7aR,8S,11aS,12aS)-8-Methyl-5,6,7a,8,11a,12,12a,13-octahydro-7H-9-oxa-6a,13-diaza-indeno[2,1-a]anthracene-11-carboxylic acid methyl ester |
| [2,3-a]pyrano[3,4-g]quinolizine-1-carboxylate |
| 16,17-Didehydro-19-methyloxayohimban-16-carboxylic acid methyl ester |
| 19-Epiajmalicine |
| 19b-methyl-16-methoxycarbonyl-16,17-didehydro-oxayohimbane |
| 4-27-00-07927 (Beilstein Handbook Reference) |
| 483-04-5 |
| 483A045 |
| 4a,5,7,8,13,13b,14,14a-octahydro-4H-indolo |
| 4QJL8OX71Z |
| AC-20175 |
| AC1L9C1B |
| ACon1_001630 |
| Ajmalicin |
| Ajmalicine |
| Ajmalicine(-Yohimbine) |
| AJN |
| AKOS015895125 |
| Alkaloid C |
| Alkaloid F |
| Alkaloid II |
| API0004044 |
| AS-35306 |
| BDBM50030612 |
| BPBio1_000512 |
| BRD-K83028735-001-01-6 |
| BRD-K83028735-003-03-8 |
| BRN 0097268 |
| BSPBio_000464 |
| C09024 |
| C21H24N2O3 |
| CAS-4373-34-6 |
| CAS-6474-90-4 |
| CHEBI:2524 |
| CHEMBL123325 |
| Circolene |
| Cristanyl |
| D08470 |
| del.-Yohimbine |
| delta-Yohimbine |
| DivK1c_006521 |
| EINECS 207-589-5 |
| GRTOGORTSDXSFK-XJTZBENFSA-N |
| GTPL8746 |
| Hydrosarpan |
| KBio1_001465 |
| KBio2_001255 |
| KBio2_003823 |
| KBio2_006391 |
| KBioSS_001255 |
| Lamuran |
| Lamuran (TN) |
| LS-15651 |
| LS-187727 |
| MEGxp0_001818 |
| Methyl (19-methyl-16,17-dehydro-18-oxa-3alpha,15alpha,19beta,20beta-yohimban-16-carboxylat) |
| Methyl (19alpha)-19-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate |
| methyl (19alpha)-19-methyl-16,17-didehydrooxayohimban-16-carboxylate |
| methyl (4S,4aR,13bS,14aS)-4-methyl-4a,5,7,8,13,13b,14,14a-octahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizine-1-carboxylate |
| Methyl 16,17-didehydro-19alpha-methyl-18-oxayohimban-16-carboxylat |
| NCGC00016647-01 |
| NCGC00016647-02 |
| NCGC00016647-03 |
| NCGC00016647-04 |
| NSC 72133 |
| Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-.alpha).- |
| Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-alpha)- |
| Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-alpha)- (9CI) |
| Oxayohimban-16-carboxylicacid, 16,17-didehydro-19-methyl-, methyl ester, (19a)- |
| Prestwick0_000592 |
| Prestwick1_000592 |
| Prestwick2_000592 |
| Prestwick3_000592 |
| py-Tetrahydroserpentine |
| Ranitol |
| Raubaserp |
| Raubasil |
| Raubasin |
| Raubasine |
| Raubasine (DCF) |
| Raubasine,(S) |
| Raumalina |
| Rauvasan |
| rauwolfia alkaloid |
| Sarpan |
| SC-80963 |
| SCHEMBL309914 |
| SPBio_002683 |
| SpecPlus_000425 |
| Spectrum_000775 |
| Substance II |
| Tensyl |
| Tetrahydroserpentine |
| UNII-4QJL8OX71Z |
| Vincain |
| Vincein |
| Vinceine |
| W-106052 |
| ZINC53147422 |
US Patents and Regulatory Information for rauwolfia serpentina root
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | RAUWOLFIA SERPENTINA | rauwolfia serpentina root | TABLET;ORAL | 080907-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Panray | KOGLUCOID | rauwolfia serpentina root | TABLET;ORAL | 009278-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Valeant Pharm Intl | RAUWOLFIA SERPENTINA | rauwolfia serpentina root | TABLET;ORAL | 009668-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Purepac Pharm | RAUWOLFIA SERPENTINA | rauwolfia serpentina root | TABLET;ORAL | 080842-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
